Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars Lindholm, Steven Snapinn, Hans Wedel et al.|The Lancet|2002

Cited by 1.6k